NCT07182058View on ClinicalTrials.gov

Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions

PARKINSON DISEASE (Disorder)

Interventions

DEVICE

Transcranial Electrical Stimulation Device

The Sphere V3.0 is a non-invasive transcranial electrical stimulation device that delivers amplitude-modulated transcranial pulsed random noise stimulation (am-tPRNS).

Trial Locations (1)

44124

U LLC Headquarters, Cleveland

All Listed Sponsors

lead

U: The Mind Company

INDUSTRY

NCT07182058 - Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms | Biotech Hunter | Biotech Hunter